ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer

Lou, Shenghan; Wang, Yufei; Zhang, Jian; Yin, Xin; Zhang, Yao; Wang, Yimin; Xue, Yingwei*哈尔滨医科大学
Frontiers in Immunology2022-1-10DOI: 10.3389/fimmu.2021.806324
6被引11阅读
引用收藏
分享

摘要

DNA damage repair (DDR) comprises the detection and correction of alterations in the chemical structure of DNA. The dysfunction of the DDR process has been determined to have important implications for tumor carcinogenesis, malignancy progression, treatment resistance, and prognosis assessment. However, the role of the DDR process in gastric cancer (GC) remains to be fully understood. Thus, a total of 2,019 GC samples from our hospital (Harbin Medical University Cancer Hospital in china) and 12 public data sets were included in our study. In this study, single-sample gene set enrichment analysis (ssGSEA) was used to generate the DDR pathway activity profiles of 8 DDR sub-pathways and identify a DDR pathway signature by combining the DDR sub-pathway gene sets. The DDR pathway profiling's impacts on the clinical outcomes, biological functions, genetic variants, immune heterogeneity, and treatment responses were analyzed through multidimensional genomics and clinical data. The results demonstrate that the DDR pathway profiling was clearly distinguished between tumor and normal tissues. The DDR pathway profiling reveals patient-level variations, which may contribute to explaining the high heterogeneity of human GC for the biological features and treatment outcomes. Thus, tumors with low DDR signature scores were independently correlated with shorter overall survival time and significantly associated with mesenchymal, invasion, and metastasis phenotypes. The statistical model integrating this DDR pathway signature with other clinical predictors outperforms each predictor alone for predicting overall survival in discrimination, calibration, and net clinical benefit. Moreover, low DDR signature scores were tightly associated with genome stability, characterized by low tumor mutational burden (TMB) and low fractions of genome alteration. Furthermore, this study confirms that patients with low DDR pathway signature scores might not benefit from adjuvant chemotherapy and a monoclonal antibody directed against programmed cell death-1 ligand 1 (anti-PD1) therapy. These findings highlighted that the DDR pathway profiling confers important implications for patients with GC and provides insights into the specific clinical and molecular features underlying the DDR process, which may help to facilitate clinical management.

学科与关键词

关键词
DNA damage repairgastric cancerprognosistumor microenvironmentchemotherapyimmunotherapy
相关
加载中…
  • Analysis of DNA Repair-Related Prognostic Function and Mechanism in Gastric Cancer
    Wang, Liqiang; Lu, Jianping; Song, Ying; Bai, Jing; Sun, Wenjing; Yu, Jingcui; Cai, Mengdi*; Fu, Songbin*Frontiers in Cell and Developmental Biology, 2022, 10: 897096.
  • A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer
    Ding, Ke; He, Youhua; Wei, Jinfen; Fu, Shuying; Wang, Jiajian; Chen, Zixi; Zhang, Haibo; Qu, Yimo; Liang, Keying; Gong, Xiaocheng; Qiu, Li; Chen, Dong; Xiao, Botao*; Du, Hongli*Frontiers in Immunology, 2022, 13: 943090.被引 3
  • Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study
    Xiao, Yanni; Lu, Di; Lei, Mingxing; Xie, Wenzhuan; Chen, Yaoxu; Zheng, Yating; Wang, Chunli; Zhao, Jing; Zhu, Zhen; Zhao, Xiaochen; Huang, Mengli; Lin, Youen*; Li, Zhongjun*; Yang, Li*Annals of Translational Medicine, 2021, 9(22): 1661.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-01-10
卷期
第 12 卷
页码
806324
DOI
10.3389/fimmu.2021.806324
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Harbin Medical University Cancer Hospital [Nn10]; [Nn102017-03]

作者

  • L

    Lou, Shenghan (第一作者)

    harbin med univ

  • W

    Wang, Yufei

    harbin med univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Jian

    harbin med univ

  • Y

    Yin, Xin

    harbin med univ

  • Z

    Zhang, Yao

    harbin med univ

  • W

    Wang, Yimin

    harbin med univ

  • X

    Xue, Yingwei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417